+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Sep 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 112
The intent behind this report is to assist the client to understand the market in terms of market definition, segmentation, market drivers, market trends, opportunities, and the challenges that the market is dealing with predominant areas and most influential countries. Deep research and analysis had been accomplished during the preparation of the report. Market statistics and facts are taken from reliable sources such as websites, Bloomberg, and Factiva annual reviews of the companies, journals, and others and were checked and validated by industry experts. The statistics and information are represented in the record through the usage of diagrams, graphs, pie charts, and different pictorial representations.
The Imatinib Drug Market Research report offers the market growth estimation, size and forecasts for the Imatinib Drug Market for every section, of the report the market trends and forecasts are done on the premise of revenue (USD million).
Imatinib Drug Market impact analysis by segments,
Based on Types,
Tablets
Capsules
Based on the Application,
Chronic Myelogenous Leukemia
Gastrointestinal Stromal Tumors
Others
By Geography -
Based on Geography, the Global Imatinib Drug Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. Countries covered are U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, Taiwan, Southeast Asia, Mexico, and Brazil, etc.
Competitive Landscape
The worldwide landscape of the Imatinib Drug Market report includes company profiles that give elaborated data like Business overview, Offerings and Specifications, Key money Metrics (Total, Gross & Net), COVID-19 impact analysis, SWOT Analysis, Market Share, Production & capability (MW), Key Development Activities, etc for producers
Companies covered are
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
COVID-19 Impact Analysis on Imatinib Drug Market COVID-19 affects the worldwide financial system in economic crisis by affecting varied industries like manufacturing, with the help of developing delivery chain and market disruption, and by way of its financial effect on companies and financial markets. Research is predicting the market outlook across the globe, and explains that the market will generate remunerative prospects for Vendors who submit the COVID-19 crisis.
The Market Research analyst will give you thorough insightful information on Imatinib Drug Size, the competitive landscape is delivered i.e. Revenue Share Analysis (MN USD) by top key Players, Revenue Market Share (%) by key Players and further, a qualitative analysis is made headed for market cognizance rate, product differentiation, and new entrants are also considered in heat map concentration.
Our Research Covers Competitors
- Company Profile
- Main Business Information
- SWOT Analysis
- Sales, Revenue, Price, and Gross Margin
- Market Share
Target Audience of the Imatinib Drug in this Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Key Report Deliverables in the report Imatinib Drug
- What is the market size and growth rate?
- Inclusive details of factors that will challenge the growth of the market pre & post-COVID-19 with 4 types of market recovery scenarios including V-shaped recovery, U-shaped recovery, L-shaped recovery, and W-shaped recovery?
- What are the factors anticipated to drive the global market?
- What are trends, restraints, and challenges in the global market?
- Segment-wise analysis of the global market?
- Regional as well as country-level analysis for the market?
- Who are the potential customers of the global market?
- Analysis of major strategies by key market players?
- How are collaborations evolving in the market?
- How is the competitive environment?
- Which region has an attractive investment proposition?
- Competitive Landscape with numerous analyses including revenue analysis, geographic presence analysis, competitive benchmarking, company evaluation matrix, competitive landscape, market positioning analysis, key strategies analysis, and others?
Table of Content- Some Points Covered in the Report
If you are looking for a detailed TOC then speak with our analyst and fill out the inquiry form.
Chapter- 1. Research Framework (Research Objective, Market Segmentation).
Chapter- 2. Research Methodology- Qualitative Research, Primary & Secondary Sources, Quantitative Research, Primary & Secondary Sources, Market Size Estimation, Data Triangulation
Chapter- 3. Executive Summary (Overview)
Chapter- 4. Market Dynamics- Global Industry Outlook, Porter's Five Forces Model, COVID-19 Impact Assessment on Market, Major Strategies Adopted by Key Players, Market Positioning of Key Players
Chapter- 5. Global Analysis, by Market Segmentation- Key Insights, Market Size, and Forecast
Chapter- 6. Global Analysis, by Geography- Key Insights, Market Size, and Forecast (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Chapter- 7. North America Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation).
Chapter- 8. Europe Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation).
Chapter- 9. Asia Pacific Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation).
Chapter- 10. Latin America Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation).
Chapter- 11. Middle East & Africa Analysis- (Key Insights, Market Size, and Forecast, By Market Segmentation).
Chapter- 12. Company Profiles- (Company, Company Basic Information, Manufacturing Base, Sales Area, Company Sales, and Net Income Highlights, Business Overview, Company News.
Thanks for reading the article. We can also customize the report consistent with your requirements.
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Imatinib Drug Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Tablets
1.2.3 Capsules
1.3 Market Segment by Application
1.3.1 Global Imatinib Drug Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Chronic Myelogenous Leukemia
1.3.3 Gastrointestinal Stromal Tumors
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Imatinib Drug Market Size (2017-2028)
2.1.1 Global Imatinib Drug Revenue (2017-2028)
2.1.2 Global Imatinib Drug Sales (2017-2028)
2.2 Global Imatinib Drug Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Imatinib Drug Sales by Regions (2017-2022)
2.2.2 Global Imatinib Drug Revenue by Regions (2017-2022)
2.3 Global Imatinib Drug Market Size Forecast by Region
2.3.1 Global Imatinib Drug Sales Forecast by Region (2023-2028)
2.3.2 Global Imatinib Drug Revenue Forecast by Region (2023-2028)
2.4 Global Top Imatinib Drug Regions (Countries) Ranking by Market Size
2.5 Imatinib Drug Market Dynamics
2.5.1 Imatinib Drug Market Trends
2.5.2 Imatinib Drug Market Drivers
2.5.3 Imatinib Drug Market Challenges
2.5.4 Imatinib Drug Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Imatinib Drug Manufacturers by Sales (2017-2022)
3.1.1 Global Imatinib Drug Sales by Manufacturers (2017-2022)
3.1.2 Global Imatinib Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Imatinib Drug Sales in 2021
3.2 Global Top Manufacturers Imatinib Drug by Revenue
3.2.1 Global Imatinib Drug Revenue by Manufacturers (2017-2022)
3.2.2 Top Imatinib Drug Manufacturers Covered: Ranking by Revenue
3.2.3 Global Imatinib Drug Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Imatinib Drug Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drug as of 2021)
3.4 Global Imatinib Drug Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Imatinib Drug Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Imatinib Drug Market
3.7 Key Manufacturers Imatinib Drug Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Imatinib Drug Market Size by Type
4.1 Global Imatinib Drug Historic Market Review by Type (2017-2022)
4.1.1 Global Imatinib Drug Sales Market Share by Type (2017-2022)
4.1.2 Global Imatinib Drug Revenue Market Share by Type (2017-2022)
4.1.3 Imatinib Drug Price by Type (2017-2022)
4.2 Global Imatinib Drug Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Imatinib Drug Sales Forecast by Type (2023-2028)
4.2.2 Global Imatinib Drug Revenue Forecast by Type (2023-2028)
4.2.3 Imatinib Drug Price Forecast by Type (2023-2028)
5 Global Imatinib Drug Market Size by Application
5.1 Global Imatinib Drug Historic Market Review by Application (2017-2022)
5.1.1 Global Imatinib Drug Sales Market Share by Application (2017-2022)
5.1.2 Global Imatinib Drug Revenue Market Share by Application (2017-2022)
5.1.3 Imatinib Drug Price by Application (2017-2022)
5.2 Global Imatinib Drug Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Imatinib Drug Sales Forecast by Application (2023-2028)
5.2.2 Global Imatinib Drug Revenue Forecast by Application (2023-2028)
5.2.3 Imatinib Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Imatinib Drug Sales Breakdown by Company
6.1.1 North America Imatinib Drug Sales by Company (2017-2022)
6.1.2 North America Imatinib Drug Revenue by Company (2017-2022)
6.2 North America Imatinib Drug Market Size by Type
6.2.1 North America Imatinib Drug Sales by Type (2017-2028)
6.2.2 North America Imatinib Drug Revenue by Type (2017-2028)
6.3 North America Imatinib Drug Market Size by Application
6.3.1 North America Imatinib Drug Sales by Application (2017-2028)
6.3.2 North America Imatinib Drug Revenue by Application (2017-2028)
6.4 North America Imatinib Drug Market Size by Country
6.4.1 North America Imatinib Drug Sales by Country (2017-2028)
6.4.2 North America Imatinib Drug Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Imatinib Drug Sales Breakdown by Company
7.1.1 Europe Imatinib Drug Sales by Company (2017-2022)
7.1.2 Europe Imatinib Drug Revenue by Company (2017-2022)
7.2 Europe Imatinib Drug Market Size by Type
7.2.1 Europe Imatinib Drug Sales by Type (2017-2028)
7.2.2 Europe Imatinib Drug Revenue by Type (2017-2028)
7.3 Europe Imatinib Drug Market Size by Application
7.3.1 Europe Imatinib Drug Sales by Application (2017-2028)
7.3.2 Europe Imatinib Drug Revenue by Application (2017-2028)
7.4 Europe Imatinib Drug Market Size by Country
7.4.1 Europe Imatinib Drug Sales by Country (2017-2028)
7.4.2 Europe Imatinib Drug Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Imatinib Drug Sales Breakdown by Company
8.1.1 Asia Pacific Imatinib Drug Sales by Company (2017-2022)
8.1.2 Asia Pacific Imatinib Drug Revenue by Company (2017-2022)
8.2 Asia Pacific Imatinib Drug Market Size by Type
8.2.1 Asia Pacific Imatinib Drug Sales by Type (2017-2028)
8.2.2 Asia Pacific Imatinib Drug Revenue by Type (2017-2028)
8.3 Asia Pacific Imatinib Drug Market Size by Application
8.3.1 Asia Pacific Imatinib Drug Sales by Application (2017-2028)
8.3.2 Asia Pacific Imatinib Drug Revenue by Application (2017-2028)
8.4 Asia Pacific Imatinib Drug Market Size by Region
8.4.1 Asia Pacific Imatinib Drug Sales by Region
8.4.2 Asia Pacific Imatinib Drug Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Imatinib Drug Sales Breakdown by Company
9.1.1 Latin America Imatinib Drug Sales by Company (2017-2022)
9.1.2 Latin America Imatinib Drug Revenue by Company (2017-2022)
9.2 Latin America Imatinib Drug Market Size by Type
9.2.1 Latin America Imatinib Drug Sales by Type (2017-2028)
9.2.2 Latin America Imatinib Drug Revenue by Type (2017-2028)
9.3 Latin America Imatinib Drug Market Size by Application
9.3.1 Latin America Imatinib Drug Sales by Application (2017-2028)
9.3.2 Latin America Imatinib Drug Revenue by Application (2017-2028)
9.4 Latin America Imatinib Drug Market Size by Country
9.4.1 Latin America Imatinib Drug Sales by Country (2017-2028)
9.4.2 Latin America Imatinib Drug Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Imatinib Drug Sales Breakdown by Company
10.1.1 Middle East and Africa Imatinib Drug Sales by Company (2017-2022)
10.1.2 Middle East and Africa Imatinib Drug Revenue by Company (2017-2022)
10.2 Middle East and Africa Imatinib Drug Market Size by Type
10.2.1 Middle East and Africa Imatinib Drug Sales by Type (2017-2028)
10.2.2 Middle East and Africa Imatinib Drug Revenue by Type (2017-2028)
10.3 Middle East and Africa Imatinib Drug Market Size by Application
10.3.1 Middle East and Africa Imatinib Drug Sales by Application (2017-2028)
10.3.2 Middle East and Africa Imatinib Drug Revenue by Application (2017-2028)
10.4 Middle East and Africa Imatinib Drug Market Size by Country
10.4.1 Middle East and Africa Imatinib Drug Sales by Country (2017-2028)
10.4.2 Middle East and Africa Imatinib Drug Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 U.A.E
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Corporation Information
11.1.2 Novartis Overview
11.1.3 Novartis Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Novartis Imatinib Drug Products and Services
11.1.5 Novartis Imatinib Drug SWOT Analysis
11.1.6 Novartis Recent Developments
11.2 Glenmark Pharmaceuticals Ltd.
11.2.1 Glenmark Pharmaceuticals Ltd. Corporation Information
11.2.2 Glenmark Pharmaceuticals Ltd. Overview
11.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Glenmark Pharmaceuticals Ltd. Imatinib Drug Products and Services
11.2.5 Glenmark Pharmaceuticals Ltd. Imatinib Drug SWOT Analysis
11.2.6 Glenmark Pharmaceuticals Ltd. Recent Developments
11.3 Sun Pharmaceuticals
11.3.1 Sun Pharmaceuticals Corporation Information
11.3.2 Sun Pharmaceuticals Overview
11.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sun Pharmaceuticals Imatinib Drug Products and Services
11.3.5 Sun Pharmaceuticals Imatinib Drug SWOT Analysis
11.3.6 Sun Pharmaceuticals Recent Developments
11.4 Actavis Generics
11.4.1 Actavis Generics Corporation Information
11.4.2 Actavis Generics Overview
11.4.3 Actavis Generics Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Actavis Generics Imatinib Drug Products and Services
11.4.5 Actavis Generics Imatinib Drug SWOT Analysis
11.4.6 Actavis Generics Recent Developments
11.5 Dr. Reddy's Laboratories
11.5.1 Dr. Reddy's Laboratories Corporation Information
11.5.2 Dr. Reddy's Laboratories Overview
11.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Dr. Reddy's Laboratories Imatinib Drug Products and Services
11.5.5 Dr. Reddy's Laboratories Imatinib Drug SWOT Analysis
11.5.6 Dr. Reddy's Laboratories Recent Developments
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Corporation Information
11.6.2 Teva Pharmaceutical Industries Ltd. Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Teva Pharmaceutical Industries Ltd. Imatinib Drug Products and Services
11.6.5 Teva Pharmaceutical Industries Ltd. Imatinib Drug SWOT Analysis
11.6.6 Teva Pharmaceutical Industries Ltd. Recent Developments
11.7 Sanofi S.A.
11.7.1 Sanofi S.A. Corporation Information
11.7.2 Sanofi S.A. Overview
11.7.3 Sanofi S.A. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Sanofi S.A. Imatinib Drug Products and Services
11.7.5 Sanofi S.A. Imatinib Drug SWOT Analysis
11.7.6 Sanofi S.A. Recent Developments
11.8 Cipla Inc.
11.8.1 Cipla Inc. Corporation Information
11.8.2 Cipla Inc. Overview
11.8.3 Cipla Inc. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Cipla Inc. Imatinib Drug Products and Services
11.8.5 Cipla Inc. Imatinib Drug SWOT Analysis
11.8.6 Cipla Inc. Recent Developments
11.9 Apotex Inc.
11.9.1 Apotex Inc. Corporation Information
11.9.2 Apotex Inc. Overview
11.9.3 Apotex Inc. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Apotex Inc. Imatinib Drug Products and Services
11.9.5 Apotex Inc. Imatinib Drug SWOT Analysis
11.9.6 Apotex Inc. Recent Developments
11.10 Mylan Pharms Inc.
11.10.1 Mylan Pharms Inc. Corporation Information
11.10.2 Mylan Pharms Inc. Overview
11.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 Mylan Pharms Inc. Imatinib Drug Products and Services
11.10.5 Mylan Pharms Inc. Imatinib Drug SWOT Analysis
11.10.6 Mylan Pharms Inc. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Imatinib Drug Value Chain Analysis
12.2 Imatinib Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drug Production Mode & Process
12.4 Imatinib Drug Sales and Marketing
12.4.1 Imatinib Drug Sales Channels
12.4.2 Imatinib Drug Distributors
12.5 Imatinib Drug Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Imatinib Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Global Imatinib Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Imatinib Drug Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 7. Global Imatinib Drug Sales Market Share by Region (2017-2022)
Table 8. Global Imatinib Drug Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Imatinib Drug Revenue Market Share by Region (2017-2022)
Table 10. Global Imatinib Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 11. Global Imatinib Drug Sales Market Share Forecast by Region (2023-2028)
Table 12. Global Imatinib Drug Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 13. Global Imatinib Drug Revenue Market Share Forecast by Region (2023-2028)
Table 14. Top Imatinib Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 15. Imatinib Drug Market Trends
Table 16. Imatinib Drug Market Drivers
Table 17. Imatinib Drug Market Challenges
Table 18. Imatinib Drug Market Restraints
Table 19. Global Imatinib Drug Sales by Manufacturers (2017-2022) & (K Units)
Table 20. Global Imatinib Drug Sales Share by Manufacturers (2017-2022)
Table 21. Global Imatinib Drug Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 22. Ranking of Global Top Imatinib Drug Manufacturers by Revenue (US$ Million) in 2021
Table 23. Imatinib Drug Revenue Share by Manufacturers (2017-2022)
Table 24. Global Imatinib Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Imatinib Drug as of 2021)
Table 26. Key Manufacturers Imatinib Drug Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 27. Key Manufacturers Imatinib Drug Plants/Factories Distribution
Table 28. Key Manufacturers Imatinib Drug Area Served
Table 29. Date of Key Manufacturers Enter into Imatinib Drug Market
Table 30. Key Manufacturers Imatinib Drug Product Type
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Imatinib Drug Sales (K Units) by Type (2017-2022)
Table 33. Global Imatinib Drug Sales Share by Type (2017-2022)
Table 34. Global Imatinib Drug Revenue (US$ Million) Market Share by Type (2017-2022)
Table 35. Global Imatinib Drug Price (K Units) by Type (2017-2022)
Table 36. Global Imatinib Drug Sales (K Units) by Type (2023-2028)
Table 37. Global Imatinib Drug Sales Share by Type (2023-2028)
Table 38. Global Imatinib Drug Revenue (US$ Million) Market Share by Type (2023-2028)
Table 39. Global Imatinib Drug Revenue Share by Type (2023-2028)
Table 40. Global Imatinib Drug Price (K Units) by Type (2023-2028)
Table 41. Global Imatinib Drug Sales (K Units) by Application (2017-2022)
Table 42. Global Imatinib Drug Sales Share by Application (2017-2022)
Table 43. Global Imatinib Drug Revenue (US$ Million) Market Share by Application (2017-2022)
Table 44. Global Imatinib Drug Price (K Units) by Application (2017-2022)
Table 45. Global Imatinib Drug Sales (K Units) by Application (2023-2028)
Table 46. Global Imatinib Drug Sales Share by Application (2023-2028)
Table 47. Global Imatinib Drug Revenue (US$ Million) Market Share by Application (2023-2028)
Table 48. Global Imatinib Drug Revenue Share by Application (2023-2028)
Table 49. Global Imatinib Drug Price (K Units) by Application (2023-2028)
Table 50. North America Imatinib Drug Sales by Company (2017-2022) & (K Units)
Table 51. North America Imatinib Drug Sales Market Share by Company (2017-2022)
Table 52. North America Imatinib Drug Revenue by Company (2017-2022) & (US$ Million)
Table 53. North America Imatinib Drug Revenue Market Share by Company (2017-2022)
Table 54. North America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 55. North America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 56. North America Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 57. North America Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 58. North America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 59. North America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 60. North America Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 61. North America Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 62. North America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 63. North America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 64. North America Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 65. North America Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 66. Europe Imatinib Drug Sales by Company (2017-2022) & (K Units)
Table 67. Europe Imatinib Drug Sales Market Share by Company (2017-2022)
Table 68. Europe Imatinib Drug Revenue by Company (2017-2022) & (US$ Million)
Table 69. Europe Imatinib Drug Revenue Market Share by Company (2017-2022)
Table 70. Europe Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 71. Europe Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 72. Europe Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 73. Europe Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 74. Europe Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 75. Europe Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 76. Europe Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 77. Europe Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 78. Europe Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 79. Europe Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 80. Europe Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 81. Europe Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 82. Asia Pacific Imatinib Drug Sales by Company (2017-2022) & (K Units)
Table 83. Asia Pacific Imatinib Drug Sales Market Share by Company (2017-2022)
Table 84. Asia Pacific Imatinib Drug Revenue by Company (2017-2022) & (US$ Million)
Table 85. Asia Pacific Imatinib Drug Revenue Market Share by Company (2017-2022)
Table 86. Asia Pacific Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 87. Asia Pacific Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 88. Asia Pacific Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 89. Asia Pacific Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 90. Asia Pacific Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 91. Asia Pacific Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 92. Asia Pacific Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 93. Asia Pacific Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 94. Asia Pacific Imatinib Drug Sales by Region (2017-2022) & (K Units)
Table 95. Asia Pacific Imatinib Drug Sales by Region (2023-2028) & (K Units)
Table 96. Asia Pacific Imatinib Drug Revenue by Region (2017-2022) & (US$ Million)
Table 97. Asia Pacific Imatinib Drug Revenue by Region (2023-2028) & (US$ Million)
Table 98. Latin America Imatinib Drug Sales by Company (2017-2022) & (K Units)
Table 99. Latin America Imatinib Drug Sales Market Share by Company (2017-2022)
Table 100. Latin America Imatinib Drug Revenue by Company (2017-2022) & (US$ Million)
Table 101. Latin America Imatinib Drug Revenue Market Share by Company (2017-2022)
Table 102. Latin America Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 103. Latin America Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 104. Latin America Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 105. Latin America Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 106. Latin America Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 107. Latin America Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 108. Latin America Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 109. Latin America Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 110. Latin America Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 111. Latin America Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 112. Latin America Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 113. Latin America Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 114. Middle East and Africa Imatinib Drug Sales by Company (2017-2022) & (K Units)
Table 115. Middle East and Africa Imatinib Drug Sales Market Share by Company (2017-2022)
Table 116. Middle East and Africa Imatinib Drug Revenue by Company (2017-2022) & (US$ Million)
Table 117. Middle East and Africa Imatinib Drug Revenue Market Share by Company (2017-2022)
Table 118. Middle East and Africa Imatinib Drug Sales by Type (2017-2022) & (K Units)
Table 119. Middle East and Africa Imatinib Drug Sales by Type (2023-2028) & (K Units)
Table 120. Middle East and Africa Imatinib Drug Revenue by Type (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Imatinib Drug Revenue by Type (2023-2028) & (US$ Million)
Table 122. Middle East and Africa Imatinib Drug Sales by Application (2017-2022) & (K Units)
Table 123. Middle East and Africa Imatinib Drug Sales by Application (2023-2028) & (K Units)
Table 124. Middle East and Africa Imatinib Drug Revenue by Application (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Imatinib Drug Revenue by Application (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Imatinib Drug Sales by Country (2017-2022) & (K Units)
Table 127. Middle East and Africa Imatinib Drug Sales by Country (2023-2028) & (K Units)
Table 128. Middle East and Africa Imatinib Drug Revenue by Country (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Imatinib Drug Revenue by Country (2023-2028) & (US$ Million)
Table 130. Novartis Corporation Information
Table 131. Novartis Description and Overview
Table 132. Novartis Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 133. Novartis Imatinib Drug Product and Services
Table 134. Novartis Imatinib Drug SWOT Analysis
Table 135. Novartis Recent Developments
Table 136. Glenmark Pharmaceuticals Ltd. Corporation Information
Table 137. Glenmark Pharmaceuticals Ltd. Description and Overview
Table 138. Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 139. Glenmark Pharmaceuticals Ltd. Imatinib Drug Product and Services
Table 140. Glenmark Pharmaceuticals Ltd. Imatinib Drug SWOT Analysis
Table 141. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 142. Sun Pharmaceuticals Corporation Information
Table 143. Sun Pharmaceuticals Description and Overview
Table 144. Sun Pharmaceuticals Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 145. Sun Pharmaceuticals Imatinib Drug Product and Services
Table 146. Sun Pharmaceuticals Imatinib Drug SWOT Analysis
Table 147. Sun Pharmaceuticals Recent Developments
Table 148. Actavis Generics Corporation Information
Table 149. Actavis Generics Description and Overview
Table 150. Actavis Generics Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 151. Actavis Generics Imatinib Drug Product and Services
Table 152. Actavis Generics Imatinib Drug SWOT Analysis
Table 153. Actavis Generics Recent Developments
Table 154. Dr. Reddy's Laboratories Corporation Information
Table 155. Dr. Reddy's Laboratories Description and Overview
Table 156. Dr. Reddy's Laboratories Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 157. Dr. Reddy's Laboratories Imatinib Drug Product and Services
Table 158. Dr. Reddy's Laboratories Imatinib Drug SWOT Analysis
Table 159. Dr. Reddy's Laboratories Recent Developments
Table 160. Teva Pharmaceutical Industries Ltd. Corporation Information
Table 161. Teva Pharmaceutical Industries Ltd. Description and Overview
Table 162. Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 163. Teva Pharmaceutical Industries Ltd. Imatinib Drug Product and Services
Table 164. Teva Pharmaceutical Industries Ltd. Imatinib Drug SWOT Analysis
Table 165. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 166. Sanofi S.A. Corporation Information
Table 167. Sanofi S.A. Description and Overview
Table 168. Sanofi S.A. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 169. Sanofi S.A. Imatinib Drug Product and Services
Table 170. Sanofi S.A. Imatinib Drug SWOT Analysis
Table 171. Sanofi S.A. Recent Developments
Table 172. Cipla Inc. Corporation Information
Table 173. Cipla Inc. Description and Overview
Table 174. Cipla Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 175. Cipla Inc. Imatinib Drug Product and Services
Table 176. Cipla Inc. Imatinib Drug SWOT Analysis
Table 177. Cipla Inc. Recent Developments
Table 178. Apotex Inc. Corporation Information
Table 179. Apotex Inc. Description and Overview
Table 180. Apotex Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 181. Apotex Inc. Imatinib Drug Product and Services
Table 182. Apotex Inc. Imatinib Drug SWOT Analysis
Table 183. Apotex Inc. Recent Developments
Table 184. Mylan Pharms Inc. Corporation Information
Table 185. Mylan Pharms Inc. Description and Overview
Table 186. Mylan Pharms Inc. Imatinib Drug Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 187. Mylan Pharms Inc. Imatinib Drug Product and Services
Table 188. Mylan Pharms Inc. Imatinib Drug SWOT Analysis
Table 189. Mylan Pharms Inc. Recent Developments
Table 190. Key Raw Materials Lists
Table 191. Raw Materials Key Suppliers Lists
Table 192. Imatinib Drug Distributors List
Table 193. Imatinib Drug Customers List
Table 194. Research Programs/Design for This Report
Table 195. Key Data Information from Secondary Sources
Table 196. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drug Product Picture
Figure 2. Global Imatinib Drug Sales Market Share by Type in 2021 & 2028
Figure 3. Tablets Product Picture
Figure 4. Capsules Product Picture
Figure 5. Global Imatinib Drug Sales Market Share by Application in 2021 & 2028
Figure 6. Chronic Myelogenous Leukemia Use Case
Figure 7. Gastrointestinal Stromal Tumors Use Case
Figure 8. Others Use Case
Figure 9. Imatinib Drug Report Years Considered
Figure 10. Global Imatinib Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Imatinib Drug Market Size 2017-2028 (US$ Million)
Figure 12. Global Imatinib Drug Sales (2017-2022) & (K Units)
Figure 13. Global Imatinib Drug Market Size Market Share by Region: 2021 VS 2028
Figure 14. Global Imatinib Drug Sales Market Share by Region (2017-2022)
Figure 15. Global Imatinib Drug Sales Market Share by Region in 2021
Figure 16. Global Imatinib Drug Revenue Market Share by Region in 2017 VS 2021
Figure 17. Global Imatinib Drug Sales Share by Manufacturers in 2021
Figure 18. The 5 and 10 Largest Manufacturers in the World: Market Share by Imatinib Drug Sales in 2021
Figure 19. Imatinib Drug Revenue Share by Manufacturers in 2021
Figure 20. Imatinib Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 21. Global Imatinib Drug Revenue Share by Type (2017-2022)
Figure 22. Global Imatinib Drug Revenue Growth Rate by Type in 2017 & 2021
Figure 23. Global Imatinib Drug Revenue Share by Application (2017-2022)
Figure 24. Global Imatinib Drug Revenue Growth Rate by Application in 2017 & 2021
Figure 25. North America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 26. North America Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 27. North America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 28. North America Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 29. North America Imatinib Drug Sales Share by Country (2017-2028)
Figure 30. North America Imatinib Drug Revenue Share by Country (2017-2028)
Figure 31. U.S. Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 32. Canada Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 33. Europe Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 34. Europe Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 35. Europe Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 36. Europe Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 37. Europe Imatinib Drug Sales Share by Country (2017-2028)
Figure 38. Europe Imatinib Drug Revenue Share by Country (2017-2028)
Figure 39. Germany Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 40. France Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 41. U.K. Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 42. Italy Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 43. Russia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 44. Asia Pacific Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 45. Asia Pacific Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 46. Asia Pacific Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 47. Asia Pacific Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 48. Asia Pacific Imatinib Drug Sales Share by Region (2017-2028)
Figure 49. Asia Pacific Imatinib Drug Revenue Share by Region (2017-2028)
Figure 50. China Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 51. Japan Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 52. South Korea Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 53. India Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 54. Australia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 55. Taiwan Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 56. Indonesia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 57. Thailand Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 58. Malaysia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 59. Philippines Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 60. Vietnam Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 61. Latin America Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 62. Latin America Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 63. Latin America Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 64. Latin America Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 65. Latin America Imatinib Drug Sales Share by Country (2017-2028)
Figure 66. Latin America Imatinib Drug Revenue Share by Country (2017-2028)
Figure 67. Mexico Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 68. Brazil Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 69. Argentina Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 70. Middle East and Africa Imatinib Drug Sales Market Share by Type (2017-2028)
Figure 71. Middle East and Africa Imatinib Drug Revenue Market Share by Type (2017-2028)
Figure 72. Middle East and Africa Imatinib Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East and Africa Imatinib Drug Revenue Market Share by Application (2017-2028)
Figure 74. Middle East and Africa Imatinib Drug Sales Share by Country (2017-2028)
Figure 75. Middle East and Africa Imatinib Drug Revenue Share by Country (2017-2028)
Figure 76. Turkey Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 77. Saudi Arabia Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 78. U.A.E Imatinib Drug Revenue (2017-2028) & (US$ Million)
Figure 79. Imatinib Drug Value Chain
Figure 80. Imatinib Drug Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
